Canterbury District Health Board

Christchurch, Canterbury 8140

0 studies enrolling now · 3 studies all time

What they study most

Cancer of the Prostate, Facial Angiofibroma, Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Tuberous Sclerosis, mCRPC

Studies at this site

• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex — Completed